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dic(1;15)(p11;p11) G-banding - Courtesy Catherine Roche-Lestienne, Olivier Theisen, Jean-Luc Lai. 
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Clinics and pathology 
Disease 
Myeloid malignancies 
Phenotype / Stem cell origin 
Myeloproliferative diseases (MPD) in 3 of 10 available 
cases (polycytemia vera (PV) in all 3 cases), 
myelodysplastic syndromes (MDS) in 6 cases (mainly 
refractory anaemia (RA): 5 cases; RARS in one case), 
acute myeloid leukaemia (AML) of M7 type in one 
case. 
Epidemiology 
At least 10 cases; balanced sex ratio (5M/5F); median 




Kaplan-Meier on 10 cases of dic(1;15) from the literature; 
survivals (in months) were: 4, 14, 23+, 24+, 27, 40+, 93+, 96, 
235. 
Prognosis 
About 60% of cases were still alive 2 to 8 years after 
diagnosis (see figure1), but with a too short follow up 
of a too small cohort, no real conclusions can be drawn. 
It is likely that the prognosis depend more on the 







Presents as-15, + dic(1;15) in most, if not all, cases. It 
therefore results in trisomy 1q; sole anomaly in about 
half cases, accompanied with del(5q) twice, +8 once, 
del(20q) once. 
Genes involved and Proteins 
Note: Genes involved are unknown; the translocation 
breakpoints are likely to be in heterochromatic regions. 
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